The relevancy of changes in cerebral 5-hydroxytryptamine to reserpine-produced sedation.
D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000502:physiology; D002247:Carbon Isotopes; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007267:Injections; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D051381:Rats; D012110:Reserpine / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D014316:Tritium
D000305:Adrenal Cortex Hormones; D002247:Carbon Isotopes; D006993:Hypnotics and Sedatives; D008996:Monoamine Oxidase Inhibitors; D014316:Tritium; D012701:Serotonin; D012110:Reserpine